Lois L. Wright

2.0k total citations
38 papers, 1.1k citations indexed

About

Lois L. Wright is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Lois L. Wright has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 11 papers in Infectious Diseases and 8 papers in Organic Chemistry. Recurrent topics in Lois L. Wright's work include Bone Metabolism and Diseases (15 papers), HIV/AIDS drug development and treatment (11 papers) and Natural product bioactivities and synthesis (9 papers). Lois L. Wright is often cited by papers focused on Bone Metabolism and Diseases (15 papers), HIV/AIDS drug development and treatment (11 papers) and Natural product bioactivities and synthesis (9 papers). Lois L. Wright collaborates with scholars based in United States, Italy and Brazil. Lois L. Wright's co-authors include Eric S. Furfine, Andrew Spaltenstein, Wieslaw M. Kazmierski, Barbara Maschera, Edward D. Blair, Richard Myers, Giorgio Palù, Margaret Tisdale, G. Darby and Larry R. Miller and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Lois L. Wright

37 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lois L. Wright United States 19 569 390 245 216 94 38 1.1k
John Deadman United Kingdom 21 508 0.9× 437 1.1× 216 0.9× 170 0.8× 127 1.4× 67 1.0k
James A. Nieman Canada 18 392 0.7× 448 1.1× 293 1.2× 217 1.0× 86 0.9× 28 1.1k
Hon C. Hui United States 20 580 1.0× 367 0.9× 572 2.3× 109 0.5× 83 0.9× 25 1.3k
Yu Ru China 11 671 1.2× 293 0.8× 220 0.9× 167 0.8× 191 2.0× 24 1.1k
Michèle Reboud‐Ravaux France 17 312 0.5× 358 0.9× 237 1.0× 219 1.0× 137 1.5× 45 789
John H. Tatlock United States 9 329 0.6× 318 0.8× 183 0.7× 137 0.6× 50 0.5× 11 737
J.P. Guilloteau France 13 652 1.1× 156 0.4× 195 0.8× 162 0.8× 156 1.7× 17 1.0k
Pierre Bonneau Canada 24 677 1.2× 394 1.0× 411 1.7× 257 1.2× 199 2.1× 39 1.6k
Neville J. Anthony United States 14 992 1.7× 531 1.4× 373 1.5× 315 1.5× 319 3.4× 24 1.5k
Hiromu Habashita Japan 19 555 1.0× 737 1.9× 117 0.5× 125 0.6× 122 1.3× 45 1.2k

Countries citing papers authored by Lois L. Wright

Since Specialization
Citations

This map shows the geographic impact of Lois L. Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lois L. Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lois L. Wright more than expected).

Fields of papers citing papers by Lois L. Wright

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lois L. Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lois L. Wright. The network helps show where Lois L. Wright may publish in the future.

Co-authorship network of co-authors of Lois L. Wright

This figure shows the co-authorship network connecting the top 25 collaborators of Lois L. Wright. A scholar is included among the top collaborators of Lois L. Wright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lois L. Wright. Lois L. Wright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duan, Maosheng, Wieslaw M. Kazmierski, Renae M. Crosby, et al.. (2012). Discovery of novel P3-oxo inhibitor of hepatitis C virus NS3/4A serine protease. Bioorganic & Medicinal Chemistry Letters. 22(8). 2993–2996. 1 indexed citations
2.
Barrett, David G., John G. Catalano, David N. Deaton, et al.. (2006). Novel, potent P2–P3 pyrrolidine derivatives of ketoamide-based cathepsin K inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(6). 1735–1739. 16 indexed citations
3.
Deaton, David N., Anne M. Hassell, Robert B. McFadyen, et al.. (2005). Novel and potent cyclic cyanamide-based cathepsin K inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(7). 1815–1819. 31 indexed citations
4.
Barrett, David G., David N. Deaton, Robert T. Gampe, et al.. (2005). Semicarbazone-based inhibitors of cathepsin K, are they prodrugs for aldehyde inhibitors?. Bioorganic & Medicinal Chemistry Letters. 16(4). 978–983. 12 indexed citations
5.
Barrett, David G., John G. Catalano, David N. Deaton, et al.. (2005). A structural screening approach to ketoamide-based inhibitors of cathepsin K. Bioorganic & Medicinal Chemistry Letters. 15(9). 2209–2213. 12 indexed citations
6.
Barrett, David G., David N. Deaton, Anne M. Hassell, et al.. (2005). Acyclic cyanamide-based inhibitors of cathepsin K. Bioorganic & Medicinal Chemistry Letters. 15(12). 3039–3043. 24 indexed citations
7.
Tavares, Francis X., David N. Deaton, Aaron B. Miller, Larry R. Miller, & Lois L. Wright. (2005). Ketoheterocycle-based inhibitors of cathepsin K: A novel entry into the synthesis of peptidic ketoheterocycles. Bioorganic & Medicinal Chemistry Letters. 15(17). 3891–3895. 16 indexed citations
8.
Barrett, David G., John G. Catalano, David N. Deaton, et al.. (2004). Potent and selective P2–P3 ketoamide inhibitors of cathepsin K with good pharmacokinetic properties via favorable P1′, P1, and/or P3 substitutions. Bioorganic & Medicinal Chemistry Letters. 14(19). 4897–4902. 24 indexed citations
9.
Kazmierski, Wieslaw M., et al.. (2004). Discovery of potent pyrrolidone-based HIV-1 protease inhibitors with enhanced drug-like properties. Bioorganic & Medicinal Chemistry Letters. 14(22). 5689–5692. 57 indexed citations
10.
Boros, Eric E., David N. Deaton, Anne M. Hassell, et al.. (2004). Exploration of the P2–P3 SAR of aldehyde cathepsin K inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(13). 3425–3429. 27 indexed citations
11.
Catalano, John G., David N. Deaton, Eric S. Furfine, et al.. (2004). アルデヒド系カテプシンK阻害剤のP 1 部位SAR探究. Bioorganic & Medicinal Chemistry Letters. 14(1). 275–278. 26 indexed citations
12.
Barrett, David G., John G. Catalano, David N. Deaton, et al.. (2004). Orally bioavailable small molecule ketoamide-based inhibitors of cathepsin K. Bioorganic & Medicinal Chemistry Letters. 14(10). 2543–2546. 10 indexed citations
13.
Tavares, Francis X., David N. Deaton, Larry R. Miller, & Lois L. Wright. (2004). Ketoamide-Based Inhibitors of Cysteine Protease, Cathepsin K:  P3 Modifications. Journal of Medicinal Chemistry. 47(21). 5057–5068. 13 indexed citations
14.
Kazmierski, Wieslaw M., et al.. (2004). Potent inhibitors of the HIV-1 protease incorporating cyclic urea P1–P2 scaffold. Bioorganic & Medicinal Chemistry Letters. 14(22). 5685–5687. 31 indexed citations
15.
Dalton, Bruce & Lois L. Wright. (2003). Exploring Redundancy in SocialWork Education. SHILAP Revista de lepidopterología. 1 indexed citations
16.
Catalano, John G., David N. Deaton, Stacey T. Long, et al.. (2003). Design of small molecule ketoamide-based inhibitors of cathepsin K. Bioorganic & Medicinal Chemistry Letters. 14(3). 719–722. 19 indexed citations
17.
Catalano, John G., David N. Deaton, Eric S. Furfine, et al.. (2003). Exploration of the P1 SAR of aldehyde cathepsin K inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(1). 275–278. 32 indexed citations
18.
Kazmierski, Wieslaw M., Eric S. Furfine, Andrew Spaltenstein, & Lois L. Wright. (2002). Novel spirocyclic pyrrolidones as P2/P1 mimetics in potent inhibitors of HIV-1 protease. Bioorganic & Medicinal Chemistry Letters. 12(23). 3431–3433. 39 indexed citations
19.
Wright, Lois L., et al.. (1996). Recombinant Human Immunodeficiency Virus Type 1 Reverse Transcriptase Is Heterogeneous. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 11(1). 20–30. 6 indexed citations
20.
Maschera, Barbara, G. Darby, Giorgio Palù, et al.. (1996). Human Immunodeficiency Virus. Journal of Biological Chemistry. 271(52). 33231–33235. 300 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John Deadman Breakdown of academic impact, for papers by James A. Nieman Breakdown of academic impact, for papers by Hon C. Hui Breakdown of academic impact, for papers by Yu Ru Breakdown of academic impact, for papers by Michèle Reboud‐Ravaux Breakdown of academic impact, for papers by John H. Tatlock Breakdown of academic impact, for papers by J.P. Guilloteau Breakdown of academic impact, for papers by Pierre Bonneau Breakdown of academic impact, for papers by Neville J. Anthony Breakdown of academic impact, for papers by Hiromu Habashita
Rankless by CCL
2026